Author's posts
AHIP18: How Intermountain plans to fight pharmaceutical monopolies as a generic drugmaker
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain’s Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset.”
How CVS Health boosted specialty medication adherence with secure messaging, digital engagement
After an initial pilot showed a 30% jump in optimal medication adherence for cancer patients, CVS Health rolled out a secure messaging platform across its specialty division, with customized alerts on side effects and lab draws. “The current digital interaction wasn’t enough,” Surya Singh, CMO of Specialty for CVS Health, told FierceHealthcare.